Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Iqvia Holdings Inc.

Capitalization 29.97B 25.79B 23.31B 22.32B 40.71B 2,761B 42.39B 274B 109B 1,321B 113B 110B 4,732B P/E ratio 2026 *
21.6x
P/E ratio 2027 * 18.2x
Enterprise value 43.05B 37.05B 33.47B 32.06B 58.47B 3,965B 60.89B 393B 157B 1,897B 162B 158B 6,796B EV / Sales 2026 *
2.5x
EV / Sales 2027 * 2.31x
Free-Float
67.55%
Yield 2026 *
-
Yield 2027 * -
1 day+2.33%
1 week-0.15%
Current month-0.15%
1 month-4.77%
3 months-20.14%
6 months-4.86%
Current year-20.79%
1 week 168.53
Extreme 168.53
182.93
1 month 156.66
Extreme 156.665
194.83
Current year 156.66
Extreme 156.665
247.04
1 year 134.64
Extreme 134.645
247.04
3 years 134.64
Extreme 134.645
261.73
5 years 134.64
Extreme 134.645
285.61
10 years 61.21
Extreme 61.21
285.61
Manager TitleAgeSince
Chief Executive Officer 65 2016-10-02
Director of Finance/CFO 65 2020-07-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 68 2015-02-04
Director/Board Member 60 2007-12-31
Chairman 65 2016-10-02
Change 5d. change 1-year change 3-years change Capi.($)
+2.33%-0.15%-6.83%-15.62% 29.29B
-1.09%-6.99%-11.80%-8.12% 45.49B
+0.39%-4.64%+22.35%+32.76% 33.41B
-4.00%-14.47%+15.30%+44.37% 31.32B
+1.41%-2.19%+154.50%+335.00% 19.5B
-0.30%+2.75%+64.62%+118.11% 14.77B
+1.69%+5.93%+43.79%+141.93% 13.36B
-1.64%-6.81%+23.68%+5.13% 13.21B
+1.78%-7.13%+122.89%+111.51% 12.23B
+10.92%-1.26%+23,837.15%+3,612.73% 11.55B
Average +1.15%-4.40%+2,426.57%+437.78% 22.41B
Weighted average by Cap. +0.35%-4.79%+1,258.64%+245.29%

Financials

2026 *2027 *
Net sales 17.24B 14.84B 13.41B 12.84B 23.42B 1,588B 24.39B 157B 63B 760B 64.74B 63.34B 2,722B 18.26B 15.71B 14.19B 13.6B 24.79B 1,682B 25.82B 167B 66.69B 805B 68.53B 67.05B 2,882B
Net income 1.45B 1.25B 1.13B 1.08B 1.97B 133B 2.05B 13.23B 5.29B 63.86B 5.44B 5.32B 229B 1.68B 1.45B 1.31B 1.25B 2.28B 155B 2.38B 15.35B 6.14B 74.07B 6.31B 6.17B 265B
Net Debt 13.08B 11.25B 10.17B 9.74B 17.76B 1,205B 18.5B 119B 47.77B 576B 49.09B 48.03B 2,064B 12.23B 10.52B 9.51B 9.11B 16.6B 1,126B 17.29B 112B 44.67B 539B 45.9B 44.91B 1,930B
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (54.5%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (40.6%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.9%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.5%), Europe and Africa (31.8%) and Asia/Pacific (20.7%).
Employees
93,000
Date Price Change Volume
26-03-09 178.55 $ +2.33% 1,940,400
26-03-06 174.49 $ -2.25% 1,766,022
26-03-05 178.50 $ +0.35% 2,101,693
26-03-04 177.88 $ +2.25% 1,778,975
26-03-03 173.96 $ -0.18% 1,577,293
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
178.55USD
Average target price
237.38USD
Spread / Average Target
+32.95%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW